Skip to main content

Our clinical team includes physicians, nurse practitioners, genetic counselors, dietitians, case managers and a social worker. Many clinical and basic research studies are conducted under the Metabolic Rare Disease Program (MRDP) at CHOC.

Most treatments involve specific diets and formulas that are devoid of the metabolites that cannot be broken down by metabolic patients, as well as cofactors and enzyme replacement. Clinical presentation of children with inborn metabolic diseases can be variable and nonspecific. Symptoms include failure to thrive, malnutrition, cyclic vomiting/dehydration, developmental delay/mental retardation or regression.

Patients are referred to our program with unexplained or persistent:

  • Metabolic acidosis or ketosis
  • Increased lactic acid
  • Hypoglycemia 
  • Hyperammonemia
  • Abnormal liver function tests
  • Hypoglycemia
  • Neutropenia/thrombocytopenia
  • Cataracts or corneal opacities
  • Cardiomyopathy
  • Hepatosplenomegaly
  • Intractable seizures
  • Developmental delay or loss of milestones
  • Failure to thrive

Patients are sent to us for consultation when common workups based upon any of the symptoms listed above do not lead to a clear diagnosis.

UCI-Affiliated Faculty

 

Volunteer Faculty

  • Jose E. Abdenur, MD
  • Richard Chang, MD
  • Cristel Chapel-Crespo, MD